Title |
Economic Evaluations of Gastroesophageal Reflux Disease Medical Management
|
---|---|
Published in |
PharmacoEconomics, May 2014
|
DOI | 10.1007/s40273-014-0164-8 |
Pubmed ID | |
Authors |
Andrew J. Gawron, Dustin D. French, John E. Pandolfino, Colin W. Howden |
Abstract |
Gastroesophageal reflux disease (GERD) contributes to substantial medication use and costs worldwide. Economic evaluations provide insight into the value of healthcare, taking into account cost, quality, and benefits of particular treatments. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 82 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 13 | 16% |
Researcher | 12 | 15% |
Other | 9 | 11% |
Student > Master | 8 | 10% |
Student > Postgraduate | 5 | 6% |
Other | 15 | 18% |
Unknown | 20 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 25 | 30% |
Biochemistry, Genetics and Molecular Biology | 5 | 6% |
Nursing and Health Professions | 4 | 5% |
Agricultural and Biological Sciences | 4 | 5% |
Economics, Econometrics and Finance | 3 | 4% |
Other | 17 | 21% |
Unknown | 24 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2019.
All research outputs
#2,263,437
of 22,953,506 outputs
Outputs from PharmacoEconomics
#179
of 1,858 outputs
Outputs of similar age
#24,048
of 228,233 outputs
Outputs of similar age from PharmacoEconomics
#2
of 30 outputs
Altmetric has tracked 22,953,506 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,858 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,233 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.